Skip to Content

001 (Lamivudine 150 mg)

Pill with imprint 001 is White, Four-sided and has been identified as Lamivudine 150 mg. It is supplied by Centaur Pharmaceuticals Private Limited.

Lamivudine is used in the treatment of hepatitis b; hiv infection; nonoccupational exposure; occupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Lamivudine 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 001

Lamivudine

Imprint
001
Strength
150 mg
Color
White
Size
14.00 mm
Shape
Four-sided
Availability
Prescription only
Drug Class
Nucleoside reverse transcriptase inhibitors (NRTIs)
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Centaur Pharmaceuticals Private Limited
National Drug Code (NDC)
64330-0001
Inactive Ingredients
microcrystalline cellulose, sodium starch glycolate type A potato, magnesium stearate, water, hypromellose 2910 (6 mPa.s), titanium dioxide, polyethylene glycol 400, polysorbate 80

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "001"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.